Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Hammerer P

Collect these papers and discover other ones on Labmeeting. Learn more.

[Problems, objective, and substance of early detection of prostate cancer.].

+ cite this

+ View Abstract

Börgermann C, Loertzer H, Hammerer P, Fornara P, Graefen M, and Rübben H

Der Urologe. Ausg. A 49(2):181-9, 2010 Feb - Who cited this? | PubMed ID: 20180057 | Fulltext

[PSA--Quo vadis?].

+ cite this

+ View Abstract

Börgermann C, Loertzer H, Luboldt HJ, Hammerer P, Fornara P, Graefen M, and Rübben H

Der Urologe. Ausg. A 48(9):1008, 1010, 1012-4, passim, 2009 Sep - Who cited this? | PubMed ID: 19680620 | Fulltext

A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.

+ cite this

+ View Abstract

Montorsi F, Alcaraz A, Desgrandchamps F, Hammerer P, Schröder F, and Castro R

The Prostate 69(8):895-907, 2009 Jun 1 - Who cited this? | PubMed ID: 19267353 | Fulltext

Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review.

+ cite this

+ View Abstract

Alcaraz A, Hammerer P, Tubaro A, Schröder FH, and Castro R

European urology 55(4):864-75, 2009 Apr - Who cited this? | PubMed ID: 19027219 | Fulltext

Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.

+ cite this

+ View Abstract

Jeron A, Pfoertner S, Bruder D, Geffers R, Hammerer P, Hofmann R, Buer J, and Schrader AJ

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 30(3):160-70, 2009 - Who cited this? | PubMed ID: 19609102 | Fulltext

The role of intermittent androgen deprivation in prostate cancer.

+ cite this

Boccon-Gibod L, Hammerer P, Madersbacher S, Mottet N, Prayer-Galetti T, and Tunn U

BJU international 100(4):738-43, 2007 Oct - Who cited this? | PubMed ID: 17662079 | Fulltext

European Study of Radical Prostatectomy: time trends in Europe, 1993-2005.

+ cite this

Djavan B, Ravery V, Rocco B, Zlotta A, Brausi M, Margreiter M, Hammerer P, Kaisary A, Anagnostou T, Romics I, Dobronski P, De Cobelli O, and Marberger M

BJU international 100 Suppl 2:22-5, 2007 Jul - Who cited this? | PubMed ID: 17594353 | Fulltext

[In Process Citation].

+ cite this

Börgermann C, Sieverding M, Fornara P, Graefen M, Hammerer P, Semjonow A, Schröder F, and Rübben H

Der Urologe. Ausg. A 45 Suppl 4:127-33, 2006 Sep - Who cited this? | PubMed ID: 16941115 | Fulltext

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer.

+ cite this

+ View Abstract

Tilki D, Irmak S, Oliveira-Ferrer L, Hauschild J, Miethe K, Atakaya H, Hammerer P, Friedrich MG, Schuch G, Galalae R, Stief CG, Kilic E, Huland H, and Ergun S

Oncogene 25(36):4965, 2006 Aug 17 - Who cited this? | PubMed ID: 16568082 | Fulltext

Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.

+ cite this

+ View Abstract

Hammerer PG, Kattan MW, Mottet N, and Prayer-Galetti T

BJU international 98(1):11, 2006 Jul - Who cited this? | PubMed ID: 16566811 | Fulltext

Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.

+ cite this

+ View Abstract

Mottet N, Prayer-Galetti T, Hammerer P, Kattan MW, and Tunn U

BJU international 98(1):20, 2006 Jul - Who cited this? | PubMed ID: 16566812 | Fulltext

[Nerve-sparing radical retropubic prostatectomy and pelvic lymph node excision in prostatic carcinoma].

+ cite this

Heidenreich A and Hammerer P

Aktuelle Urologie 36(5):439-56; quiz 457-9, 2005 Sep - Who cited this? | PubMed ID: 16163607 | Fulltext

Discordance analysis characteristics as a new method to compare the diagnostic accuracy of tests: example of complexed versus total prostate-specific antigen.

+ cite this

+ View Abstract

Keller T, Butz H, Lein M, Kwiatkowski M, Semjonow A, Luboldt HJ, Hammerer P, Stephan C, and Jung K

Clinical chemistry 51(3):532-9, 2005 Mar - Who cited this? | PubMed ID: 15738515 | Fulltext

Prostate cancers in the transition zone: Part 2; clinical aspects.

+ cite this

Augustin H, Erbersdobler A, Hammerer PG, Graefen M, and Huland H

BJU international 94(9):1226-9, 2004 Dec - Who cited this? | PubMed ID: 15610094 | Fulltext

[Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].

+ cite this

Hammerer P

Aktuelle Urologie 35(5):371-2, 2004 Sep - Who cited this? | PubMed ID: 15384001 | Fulltext

Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.

+ cite this

+ View Abstract

Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, and Huland H

European urology 45(6):737-43, 2004 Jun - Who cited this? | PubMed ID: 15149745 | Fulltext

Gain of androgen receptor gene copies in primary prostate cancer due to X chromosome polysomy.

+ cite this

+ View Abstract

Röpke A, Erbersdobler A, Hammerer P, Palisaar J, John K, Stumm M, and Wieacker P

The Prostate 59(1):59-68, 2004 Apr 1 - Who cited this? | PubMed ID: 14991866 | Fulltext

Management of prostate-specific antigen relapse in prostate cancer: a European Consensus.

+ cite this

+ View Abstract

Boccon-Gibod L, Djavan WB, Hammerer P, Hoeltl W, Kattan MW, Prayer-Galetti T, Teillac P, and Tunn UW

International journal of clinical practice 58(4):382-90, 2004 Apr - Who cited this? | PubMed ID: 15161124 | Fulltext

[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system].

+ cite this

Hammerer PG, Augustin H, Blonski J, Graefen M, Haese A, Erbersdobler A, Daghofer F, and Huland H

Der Urologe. Ausg. A 43(3):307-12, 2004 Mar - Who cited this? | PubMed ID: 15045191 | Fulltext

Is year of radical prostatectomy a predictor of outcome in prostate cancer?.

+ cite this

+ View Abstract

Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F, Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen M, Quinn DI,

(show remaining authors)

The Journal of urology 171(2 Pt 1):692-6, 2004 Feb - Who cited this? | PubMed ID: 14713788 | Fulltext

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

+ cite this

+ View Abstract

Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Erbersdobler A, Henke RP, Huland H, Wheeler TM, Slawin K, Scardino PT, and Kattan MW

The Journal of urology 171(1):200-3, 2004 Jan - Who cited this? | PubMed ID: 14665876 | Fulltext

pT0 after radical prostatectomy: overtreatment for insignificant prostate cancer?.

+ cite this

Hammerer P

European urology 45(1):35, 2004 Jan - Who cited this? | PubMed ID: 14667512 | Fulltext

Extracorporeal shockwave lithotripsy compared with ureteroscopy for the removal of small distal ureteral stones.

+ cite this

+ View Abstract

Hautmann S, Friedrich MG, Fernandez S, Steuber T, Hammerer P, Braun PM, Jünemann KP, and Huland H

Urologia internationalis 73(3):238-43, 2004 - Who cited this? | PubMed ID: 15539843 | Fulltext

Disease recurrence after radical prostatectomy. Contemporary diagnostic and therapeutical strategies.

+ cite this

+ View Abstract

Augustin H and Hammerer PG

Minerva urologica e nefrologica = The Italian journal of urology and nephrology 55(4):251-61, 2003 Dec - Who cited this? | PubMed ID: 14765017 | Fulltext

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

+ cite this

+ View Abstract

Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ,

(show remaining authors)

The Journal of urology 170(5):1798-803, 2003 Nov - Who cited this? | PubMed ID: 14532779 | Fulltext

Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy.

+ cite this

+ View Abstract

Augustin H, Hammerer PG, Graefen M, Palisaar J, Daghofer F, Huland H, and Erbersdobler A

Journal of cancer research and clinical oncology 129(11):662-8, 2003 Nov - Who cited this? | PubMed ID: 14513368 | Fulltext

A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations.

+ cite this

+ View Abstract

Lein M, Kwiatkowski M, Semjonow A, Luboldt HJ, Hammerer P, Stephan C, Klevecka V, Taymoorian K, Schnorr D, Recker F, Loening SA, and Jung K

The Journal of urology 170(4 Pt 1):1175-9, 2003 Oct - Who cited this? | PubMed ID: 14501719 | Fulltext

[Indications for and results of radical prostatectomy].

+ cite this

+ View Abstract

Graefen M, Hammerer PG, Haese A, and Huland H

Der Urologe. Ausg. A 42(9):1203-11, 2003 Sep - Who cited this? | PubMed ID: 14504753 | Fulltext

Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.

+ cite this

+ View Abstract

Augustin H, Graefen M, Palisaar J, Blonski J, Erbersdobler A, Daghofer F, Huland H, and Hammerer PG

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21(15):2860-8, 2003 Aug 1 - Who cited this? | PubMed ID: 12885802 | Fulltext

Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?.

+ cite this

+ View Abstract

Kuczyk M, Turkeri L, Hammerer P, Ravery V, and European Society for Oncological Urology

European urology 44(1):57-64, 2003 Jul - Who cited this? | PubMed ID: 12814676 | Fulltext

Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?.

+ cite this

+ View Abstract

Augustin H, Hammerer PG, Blonski J, Graefen M, Palisaar J, Daghofer F, Huland H, and Erbersdobler A

Urology 62(1):79-85, 2003 Jul - Who cited this? | PubMed ID: 12837427 | Fulltext

Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.

+ cite this

+ View Abstract

Augustin H, Hammerer PG, Graefen M, Erbersdobler A, Blonski J, Palisaar J, Daghofer F, and Huland H

European urology 43(5):455-60, 2003 May - Who cited this? | PubMed ID: 12705986 | Fulltext

[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].

+ cite this

+ View Abstract

Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, Fernandez S, Noldus J, Erbersdobler A, Cagiannos I, Scardino PT, Kattan MW, and Huland H

Der Urologe. Ausg. A 42(5):685-92, 2003 May - Who cited this? | PubMed ID: 12750804 | Fulltext

Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.

+ cite this

+ View Abstract

Augustin H, Erbersdobler A, Graefen M, Fernandez S, Palisaar J, Huland H, and Hammerer P

The Prostate 55(1):48-54, 2003 Apr 1 - Who cited this? | PubMed ID: 12640660 | Fulltext

Differences in biopsy features between prostate cancers located in the transition and peripheral zone.

+ cite this

+ View Abstract

Augustin H, Erbersdobler A, Graefen M, Jaekel T, Haese A, Huland H, and Hammerer PG

BJU international 91(6):477-81, 2003 Apr - Who cited this? | PubMed ID: 12656897 | Fulltext

Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.

+ cite this

+ View Abstract

Haese A, Chaudhari M, Miller MC, Epstein JI, Huland H, Palisaar J, Graefen M, Hammerer P, Poole EC, O'Dowd GJ, Partin AW, and Veltri RW

Cancer 97(4):969-78, 2003 Feb 15 - Who cited this? | PubMed ID: 12569595 | Fulltext

Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002.

+ cite this

+ View Abstract

Augustin H, Hammerer P, Graefen M, Palisaar J, Noldus J, Fernandez S, and Huland H

European urology 43(2):113-8, 2003 Feb - Who cited this? | PubMed ID: 12565767 | Fulltext

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?.

+ cite this

+ View Abstract

Friedrich MG, Hellstern A, Toma MI, Hammerer P, and Huland H

European urology 43(2):146-50; discussion 150-1, 2003 Feb - Who cited this? | PubMed ID: 12565772 | Fulltext

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

+ cite this

+ View Abstract

Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, Blonski J, Fernandez S, Erbersdobler A, and Huland H

European urology 43(1):6-10; discussion 11, 2003 Jan - Who cited this? | PubMed ID: 12507538 | Fulltext

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.

+ cite this

+ View Abstract

Steuber T, Nurmikko P, Haese A, Pettersson K, Graefen M, Hammerer P, Huland H, and Lilja H

The Journal of urology 168(5):1917-22, 2002 Nov - Who cited this? | PubMed ID: 12394676 | Fulltext

Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.

+ cite this

+ View Abstract

Djavan B, Remzi M, Zlotta AR, Ravery V, Hammerer P, Reissigl A, Dobronski P, Kaisary A, and Marberger M

Urology 60(4 Suppl 1):4-9, 2002 Oct - Who cited this? | PubMed ID: 12384156 | Fulltext

International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

+ cite this

+ View Abstract

Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein E, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20(15):3206-12, 2002 Aug 1 - Who cited this? | PubMed ID: 12149292 | Fulltext

Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.

+ cite this

+ View Abstract

Noldus J, Michl U, Graefen M, Haese A, Hammerer P, and Huland H

European urology 42(2):118-24, 2002 Aug - Who cited this? | PubMed ID: 12160581 | Fulltext

Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?.

+ cite this

+ View Abstract

Cagiannos I, Graefen M, Karakiewicz PI, Ohori M, Eastham JA, Rabbani F, Fair W, Wheeler TM, Hammerer PG, Haese A, Erbersdobler A, Huland H, Scardino PT, and Kattan MW

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20(8):2025-30, 2002 Apr 15 - Who cited this? | PubMed ID: 11956261 | Fulltext

Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

+ cite this

+ View Abstract

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Huland E, Scardino PT, Kattan MW, and Huland H

The Journal of urology 167(3):1306-9, 2002 Mar - Who cited this? | PubMed ID: 11832719 | Fulltext

Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.

+ cite this

+ View Abstract

Conrad S, Graefen M, Pichlmeier U, Henke RP, Erbersdobler A, Hammerer PG, and Huland H

The Journal of urology 167(2 Pt 1):521-5, 2002 Feb - Who cited this? | PubMed ID: 11792910 | Fulltext

Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

+ cite this

+ View Abstract

Palisaar RJ, Graefen M, Karakiewicz PI, Hammerer PG, Huland E, Haese A, Fernandez S, Erbersdobler A, Henke RP, and Huland H

European urology 41(2):155-61, 2002 Feb - Who cited this? | PubMed ID: 12074402 | Fulltext

Prediction of tumor heterogeneity in localized prostate cancer.

+ cite this

+ View Abstract

Huland H, Graefen M, Haese A, Hammerer PG, Palisaar J, Pichlmeier U, Henke RP, Erbersdobler A, Huland E, and Lilja H

The Urologic clinics of North America 29(1):213-22, 2002 Feb - Who cited this? | PubMed ID: 12109347 | Fulltext

Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.

+ cite this

+ View Abstract

Erbersdobler A, Fritz H, Schnöger S, Graefen M, Hammerer P, Huland H, and Henke RP

European urology 41(1):40-6, 2002 Jan - Who cited this? | PubMed ID: 11999464 | Fulltext

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

+ cite this

+ View Abstract

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Fernandez S, Noldus J, Erbersdobler A, Huland H, Scardino PT, and Kattan MW

Urologic oncology 7(4):141-6, 2002 - Who cited this? | PubMed ID: 12474529 | Fulltext

Search Google Scholar for Hammerer P

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Papers authored by Hammerer P

Join Labmeeting

Sponsored Product